Pascale Boissel
Director/Board Member at POXEL
Net worth: 2 360 $ as of 2024-03-30
Profile
Pascale Boissel is an Independent Director at Poxel SA since 2015, an Independent Non-Executive Director at Sartorius Stedim Biotech SA since 2019, and an Independent Member-Supervisory Board at Innate Pharma SA since 2020.
Previously, Ms. Boissel served as the Director of Finance & Administration and Deputy CEO at BioAster from 2012 to 2016, CFO and Director of Finance & Administration at ENYO Pharma SA from 2017 to 2018, Chief Financial Officer and Head of Media Relations at QIAGEN Marseille SA from 2009 to 2012, and Chief Financial Officer at Novadiscovery SAS from 2017 to 2021.
Ms. Boissel holds an undergraduate degree and an MBA from École des Hautes Études Commerciales de Paris.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INNATE PHARMA SA CLASS A
0.00% | 2022-12-30 | 1,000 ( 0.00% ) | 2 360 $ | 2024-03-30 |
Pascale Boissel active positions
| Companies | Position | Start |
|---|---|---|
| POXEL | Director/Board Member | 2015-03-04 |
| SARTORIUS STEDIM BIOTECH | Director/Board Member | 2019-03-25 |
| INNATE PHARMA | Director/Board Member | 2020-05-18 |
Former positions of Pascale Boissel
| Companies | Position | End |
|---|---|---|
Novadiscovery SAS
 Novadiscovery SAS Information Technology ServicesTechnology Services Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France. | Director of Finance/CFO | 2020-12-31 |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Director of Finance/CFO | 2018-04-30 |
BioAster
 BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Director of Finance/CFO | 2016-11-30 |
| QIAGEN MARSEILLE | Director of Finance/CFO | 2011-12-31 |
Training of Pascale Boissel
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| POXEL | Health Technology |
| INNATE PHARMA | Health Technology |
| SARTORIUS STEDIM BIOTECH | Health Technology |
| Private companies | 4 |
|---|---|
QIAGEN Marseille SA
 QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services QIAGEN Marseille SA is a molecular diagnosis company, which focuses on the development and marketing of diagnostic tests in the field of oncology. Its products are used for diagnosis, prognosis and monitoring of patients with leukemia. The company was founded by Vincent Fert, Stéphane Debono, and Fabienne Hermitte on September 23, 1999 and is headquartered in Marseille, France. | Commercial Services |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Health Technology |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Novadiscovery SAS develops mathematical model and artificial intelligence solutions for the healthcare sector. It offers risk management analytic tools for medical research programs and clinical trials. The company was founded by Fr?d?ric Cogny, Jean-Pierre Boissel, and Fran?ois-Henri Boissel in 2010 and is headquartered in Lyon, France. | Technology Services |
- Stock Market
- Insiders
- Pascale Boissel
